Krishna Institute of Medical Sciences

542.00
+4.75
(0.88%)
Market Cap
21,687.53 Cr
EPS
38.75
PE Ratio
61.72
Dividend Yield
0.00 %
52 Week High
674.30
52 Week low
350.00
PB Ratio
10.73
Debt to Equity
0.58
Sector
Hospitals
Add Ratio

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from9 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy88.89 %
88.89 %
Hold11.11 %
11.11 %
Sell0.0 %
0.0 %

Company News

View All News
Caret
positive
KIMS Enters Operations and Management Agreement with Splendid Hospitals13 hours ago
Krishna Institute of Medical Sciences (KIMS) has signed an operations and management agreement with Splendid Hospitals. Under this agreement, KIMS will be responsible for running, managing, operating, directing, and controlling the hospital, as well as providing medical services.
positive
Krishna Institute of Medical Sciences Enters Management Agreement with UAIMS Hospital2 days ago
Krishna Institute of Medical Sciences has signed an operations and management agreement with UAIMS Hospital. The initial agreement is for 7 years, with a potential extension of 3 years. As part of the deal, Krishna Institute of Medical Sciences will receive a 9% revenue fee from UAIMS Hospital.
positive
Krishna Institute of Medical Sciences Signs Operations and Management Agreement with UAIMS Hospital3 days ago
Krishna Institute of Medical Sciences has entered into an operations and management agreement with UAIMS Hospital. The initial agreement is for 7 years, with a potential extension of 3 years. As part of this agreement, Krishna Institute of Medical Sciences will receive a 9% revenue fee from UAIMS Hospital.
Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
1,031.85 1,00,309.45 93.41 5,584.10 18.77 1,058 -17.46 42.11
6,390.95 91,892.06 70.44 19,165.50 14.74 917 49.14 37.64
609.90 46,044.90 57.78 6,931.20 8.99 645 89.49 40.42
1,206.40 32,402.38 60.82 2,759.20 25.09 326 15.71 58.91
1,404.55 28,703.50 35.83 5,093.40 10.96 790 2.66 56.00
542.00 21,687.53 61.72 2,511.20 12.94 336 20.76 27.74
417.30 20,844.68 80.07 3,723.70 22.85 205 -69.22 30.11
6,150.00 15,982.15 32.44 599.90 11.69 58 8.85 58.63
1,299.55 13,197.15 54.81 1,334.00 10.76 218 10.06 32.06
1,489.85 9,768.35 50.32 1,095.50 21.32 177 20.14 38.20
Growth Rate
Revenue Growth
12.94 %
Net Income Growth
-8.15 %
Cash Flow Change
20.60 %
ROE
-14.99 %
ROCE
-23.55 %
EBITDA Margin (Avg.)
-8.15 %

Quarterly Financial Results

Quarterly Financials
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Revenue
268
206
411
361
363
478
417
398
388
501
588
569
581
609
655
609
638
693
782
790
Expenses
203
165
268
268
258
330
283
264
259
358
412
411
413
449
475
459
475
509
559
585
EBITDA
65
40
143
93
105
148
134
134
129
143
177
158
168
160
180
150
163
184
223
205
Operating Profit %
24 %
18 %
34 %
26 %
28 %
30 %
31 %
33 %
31 %
28 %
27 %
27 %
28 %
26 %
27 %
24 %
25 %
26 %
28 %
24 %
Depreciation
17
17
16
20
17
17
18
19
19
29
31
33
35
32
33
35
46
39
41
45
Interest
10
9
7
9
7
6
3
3
4
6
8
12
5
9
9
12
16
18
20
26
Profit Before Tax
38
14
120
65
81
125
113
112
107
107
138
113
127
119
139
102
100
127
162
135
Tax
10
5
29
17
22
33
29
28
24
28
31
31
29
32
37
26
29
32
42
42
Net Profit
28
9
90
48
59
92
84
84
83
79
106
82
99
87
101
77
72
95
121
93
EPS in ₹
3.72
1.49
11.21
6.55
7.72
11.48
10.34
10.14
10.08
8.74
12.14
9.49
11.65
10.10
11.50
8.98
8.18
10.82
2.68
2.22

Balance Sheet

Balance Sheet
2018
2019
2020
2021
2022
2023
2024
Total Assets
958
1,118
1,196
1,436
1,907
2,941
3,852
Fixed Assets
755
863
916
931
1,005
1,766
2,434
Current Assets
156
174
220
451
393
478
547
Capital Work in Progress
0
0
2
9
21
477
600
Investments
0
0
0
0
333
68
157
Other Assets
203
254
278
496
549
630
661
Total Liabilities
958
1,118
1,196
1,436
1,907
2,941
3,852
Current Liabilities
749
201
219
278
215
297
452
Non Current Liabilities
347
351
366
282
282
707
1,307
Total Equity
-138
566
611
876
1,411
1,938
2,093
Reserve & Surplus
-209
466
523
786
1,307
1,590
1,748
Share Capital
50
75
75
78
80
80
80

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
5
-11
5
3
-3
33
12
-27
36
-15
Investing Activities
-71
-41
-100
-64
-110
-125
-354
-412
-416
-753
Operating Activities
64
95
82
106
134
202
356
324
432
521
Financing Activities
12
-66
24
-39
-27
-44
10
61
20
217

Share Holding

% Holding
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Promoter
38.84 %
38.84 %
38.84 %
38.84 %
38.84 %
38.84 %
38.84 %
38.84 %
38.84 %
38.84 %
38.82 %
38.82 %
38.82 %
38.82 %
38.82 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
8.61 %
8.61 %
0.00 %
14.25 %
0.00 %
16.73 %
17.84 %
15.85 %
15.68 %
DIIs
13.81 %
16.11 %
18.35 %
18.49 %
20.46 %
27.98 %
28.32 %
29.76 %
33.03 %
34.80 %
31.63 %
33.13 %
32.12 %
32.30 %
32.05 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
13.14 %
14.23 %
13.38 %
12.88 %
11.81 %
11.50 %
11.32 %
11.10 %
11.22 %
11.15 %
10.84 %
10.73 %
10.61 %
10.55 %
10.97 %
Others
34.21 %
30.82 %
29.42 %
29.79 %
28.88 %
21.68 %
12.92 %
11.69 %
16.91 %
0.96 %
18.70 %
0.59 %
0.61 %
2.48 %
2.48 %
No of Share Holders
0
267
86,389
74,355
73,664
70,795
67,735
60,980
65,449
66,957
71,014
69,092
69,063
77,617
95,468

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Corporate Action

Announcements

KIMS Entered Into An Operations And Management Agreement With Splendid Hospitals Private Limited Hyderabad Telangana.
13 hours ago
Announcement under Regulation 30 (LODR)-Press Release / Media Release
3 days ago
KIMS Entered Into An Operations And Management Agreement With Ushahkal Abhinav Institute Of Medical Sciences (UAIMS Hospital) Sangli Maharashtra.
3 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
5 days ago
Announcement under Regulation 30 (LODR)-Newspaper Publication
5 days ago
Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
6 days ago
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
7 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
8 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Feb 07, 2025, 17:28
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Feb 07, 2025, 17:17
Announcement under Regulation 30 (LODR)-Newspaper Publication
Feb 07, 2025, 12:11
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Feb 06, 2025, 18:52
Announcement under Regulation 30 (LODR)-Investor Presentation
Feb 06, 2025, 18:44
Integrated Filing (Financial)
Feb 06, 2025, 17:18
Quarterly Result_31St December 2024
Feb 06, 2025, 17:02
Board Meeting Outcome for Outcome Of Board Meeting Held On 06â„¢ February 2025 Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.
Feb 06, 2025, 16:56
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Feb 05, 2025, 10:56
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Jan 31, 2025, 15:51
KIMS Swastha Private Limited (The KIMS) A Wholly-Owned Subsidiary Of Krishna Institute Of Medical Sciences Limited Has Entered Into An Agreement On 27Th January 2025 With Valiyath Institute Of Medical
Jan 28, 2025, 16:43
Board Meeting Intimation for The Approval Of The Unaudited (Standalone & Consolidated) Financial Results Of The Company For The 03Rd Quarter And Nine Months Ended December 31 2024
Jan 27, 2025, 12:04
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Jan 08, 2025, 17:31
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Jan 08, 2025, 12:43
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Jan 07, 2025, 17:46
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Jan 01, 2025, 12:31

Technical Indicators